Scratching behavior in mice associated with IgE-mediated allergic cutaneous reaction and its pharmacological characterization

Allergology International

Volumn 46, Issue 2, 1997, Pages 117-124

  Musoh, Keiichi ^a   Nakamura, Nobuaki ^a   Sakurai, Toshimi ^a   Inagaki, Naoki ^a   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

antihistamine; compound 48 80; cyproheptadine; dinitrofluorobenzene; IgE mediated allergic cutaneous reaction; prednisolone; scratching behavior

Indexed keywords

EID: 85010152310     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.46.117     Document Type: Article

References (26)

1. Denman, ST. A review of pruritus. J. Am. Acad. Dermatol. 1986; 14: 375–392.
2. Bernhard, JD. Clinical aspects of pruritus. In: Jeffers JD, Scott E, White J (eds). Dermatology in General Medicine, 3rd edn. New York: McGraw-Hill, 1987; 78–90.
3. Greaves, MW. Pruritus. In: Champion RH, Burton JL, Ebling FJG (eds). Textbook of Dermatology, 5th edn, vol. 1. Oxford: Blackwell Science, 1992; 527–535.
4. Wahlgren, C.-F. Pathophysiology of itching in urticaria and atopic dermatitis. Allergy 1992; 47: 65–75.
5. Kuraishi, Y, Nagasawa, T, Hayashi, K, Satoh, M. Scratching behavior induced by pruritogenic but not algesinogenic agents in mice. Eur. J. Pharmacol. 1995; 275: 229–233.
6. Ray, MC, Tharp, MD, Sullivan, TJ, Tigelaar, RE. Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies. J. Immunol. 1983; 131: 1096–1102.
7. Katayama, I, Tanei, R, Yokozeki, H, Nishioka, K, Dohi, Y. Induction of eczematous skin reaction in experimentally induced hyperplastic skin of Balb/c mice by monoclonal anti-DNP IgE antibody: Possible implications for skin lesion formation in atopic dermatitis. Int. Arch. Allergy Appl. Immunol. 1990; 93: 148–154.
8. Sakurai, T, Inagaki, N, Nagai, H. The effect of anti-tumor necrosis factor (TNF)-a monoclonal antibody on allergic cutaneous late phase reaction in mice. Life Sci. 1994; 54: PL291–PL295.
9. Nagai, H, Sakurai, T, Inagaki, N, Mori, H. An immunopharmacological study of the biphasic skin reaction in mice. Biol. Pharm. Bull. 1995; 18: 239–245.
10. Inagaki, N, Tsunematsu, M, Sakurai, T, Matsuo, A, Nagai, H. The effect of prednisolone on IgE-dependent biphasiccutaneous reaction in BALB/c mice. Gen. Pharmacol. 1997; 28: 93–97.
11. Musoh, K, Ohashi, T, Iwanaga, Y et al. Non-sedating antiallergic agent, HSR-609, inhibits allergic airway and peritoneal eosinophilia in mice. Proceedings of the Second Asian Pacific Congress of Allergology and Clinical Immunology, 1995; 210 (Abstract).
12. De Vos, Ch, Maleux, MR, Baltes, E, Gobert, J. Inhibition of histamine skin reaction in four animal species by UCB P071 (cetirizine 2HCI). Ann. Allergy 1985; 55: 392 (Abstract).
13. Rihoux, JP, De Vos, Ch, Baltes, E, de Lannoy, J. Pharmacoclinical investigation of cetirizine, a new potent and well-tolerated anti HI. Ann. Allergy 1985; 55: 392 (Abstract).
14. Cheng, H, Woodward, J. Antihistaminic effect of terfenadine: A new piperidine-type antihistamine. Drug Rev. Res. 1982; 2: 181–196.
15. Fjellner, B, Hägermark, Ö. Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Acta Derm. Venereal. 1981; 61: 245–250.
16. Hägermark, Ö, Hökfelt, T, Pernow, B. Flare and itch induced by substance P in human skin. J. Invest. Dermatol. 1978; 71: 233–235.
17. Armstrong, D, Dry, RML, Keele, CA, Markham, JW. Observations on chemical excitants of cutaneous pain in man. J. Physiol. 1953; 120: 326–351.
18. Keele, CA, Armstrong, D. Substance Producing Pain and Itch. Baltimore: Williams and Wilkins, 1964.
19. Davis, MG, Greaves, MW. The current status of histamine receptors in human skin: Therapeutic implications. Br. J. Dermatol. 1981; 104: 601–606.
20. Harvima, RJ, Schwartz, LB. Mast cell-derived mediators. In: Foreman JC (ed.). Immunopharmacology of mast cells and basophils. London: Academic Press, 1993; 115–138.
21. Church, MK. Drugs in asthma treatment. In: Holgate ST, Church MK (eds). Allergy. London: Gower Medical Publishing, 1993; 15.1–15.12.
22. Toogood, JH, White, FA. Corticosteroids: Mechanisms of action and treatment of allergic diseases. In: Townley RG, Agrawal DK (eds). Immunopharmacology of Allergic Diseases. New York: Marcel Dekker, 1996; 675–706.
23. Fjellner, B. Experimental and clinical pruritus. Acta Derm. Venereol. 1981; 61: 1–34.
24. McMahon, SB, Koltzenburg, M. Itching for an explanation. Trends Neurosci. 1992; 15: 497–501.
25. Bernstein, JE, Swift, RM. Relief of intractable pruritus antagonized by naloxone. Arch. Dermatol. 1979; 115: 1366–1367.
26. Jones, EA, Bergasa, NV. The pruritus of cholestasis: From bile acid to opiate agonists. Hepatology 1990; 11: 884–887.